| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgements
|
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 2 |
CRUK
|
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 3 |
Editorial Board
|
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 4 |
ESMO
|
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 5 |
Molecular Analysis for Precision Oncology Congress 2023 Officer
|
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 6 |
Notice and Disclaimer
|
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 7 |
3O Are targeted therapies effective in the relapsed or metastatic cancer setting? A Cochrane meta-analysis
|
Kazmi, F.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 8 |
8O Clinical implications of clonal hematopoiesis in the tumor microenvironment of non-small cell lung cancer
|
Pich, O.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 9 |
5O Deciphering resistance mechanisms in cancer: Insights from the final report of MATCH-R study with focus on molecular drivers
|
Beshiri, K.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 10 |
2O Dissecting intratumoral heterogeneity in localized HR+/HER2- breast cancer using single-cell DNA sequencing (scDNA-seq)
|
Tran, D.T.N.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 11 |
6O Insights into tumour dissemination and progression using longitudinal imaging and ctDNA in the TRACERx lung cancer study
|
Liu, W.K.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 12 |
7O Molecular drivers and therapeutic targets for neuroendocrine transformation in lung cancer
|
Sen, T.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 13 |
9O Pancreatic cancer risk in individuals with newly diagnosed diabetes: Insights from the AMORIS cohort in Sweden
|
Zhang, Z.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 14 |
1O SPICE: Probabilistic reconstruction of copy-number evolution in metastatic cancers
|
Bunkum, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 15 |
4O Ultra-fast deep-learned CNS tumor classification during surgery
|
Tops, B.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 16 |
64P Acidosis induces ferroptosis of breast cancer via ZFAND5/SLC3A2 axis with the synergistic effect of metformin and facilitates M1 macrophage polarization
|
Xiong, H.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 17 |
109P A multiomic, single-cell measurable residual disease (scMRD) assay for phasing DNA mutations and surface immunophenotypes
|
Formisano, S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 18 |
10P An adapted CGP-based model to interpret POLE mutations in endometrial cancer
|
Trozzi, R.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 19 |
96P Analysis of concordance between microsatellite instability by next generation sequencing (NGS-MSI) and mismatch repair deficiency by immunohistochemistry (IHC-MMR) in endometrial cancer (EC) patients
|
Duranti, S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 20 |
93P A new platform for fast-track molecular stratification of endometrial carcinomas enabling timely treatment decisions in precision oncology
|
Walz, S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 21 |
13P A novel algorithm for predicting variant detectability in oncogenomic analysis
|
Akkuş, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 22 |
112P A novel methylation-sensitive assay for early detection of hepatocellular carcinoma to improve surveillance
|
Ha, J.S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 23 |
120P Anti-angiogenic therapy or immunotherapy? A multicenter real-world study of patients with advanced non-small cell lung cancer with EGFR / HER2 exon 20 insertion mutations
|
Chu, T.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 24 |
169P A real-world molecular pre-screening program in advanced breast cancer (ABC) at Institut Català d'Oncologia l'Hospitalet: Clinical practice study to assess treatment-decision choice based on molecular results
|
Garulo, D. Lluís
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 25 |
26P Associations between cancer stem cells (CSC) markers and androgen (AR) and estrogen (ER) receptors expression in prostate cancer (PCa)
|
Puchinskaya, M.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 26 |
54P ATRX-deficient IDH-wildtype adult high-grade gliomas display novel, clinically relevant genetic patterns by comprehensive genomic profiling
|
Bedics, G.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 27 |
18P AURKB inhibition radiosensitises NSCLC by altering mitotic fate
|
Egerton, K.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 28 |
95P Automatic data processing to identify EGFR mutations in pathology reports of patients with non-small cell lung cancer (NSCLC)
|
Garcia, B. Cajiao
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 29 |
162P Barriers to tumor mutational burden (TMB) testing in oncology care: US physician survey
|
Jones, G.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 30 |
171P Benefit of next-generation sequencing for lung cancer patients in a limited-resource area
|
Thanasombunsukh, K.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 31 |
152P Biomarkers of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
|
Masotti, C.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 32 |
153P BRAF variants and therapy outcomes in melanoma
|
Chatziioannou, E.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 33 |
115P BrainStorm-NSE: Serum neuron-specific enolase as a biomarker for central nervous system metastases: A prospective cohort study
|
Martins-Branco, D.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 34 |
160P CICLADES-CE study: Genomic signatures detected in DNA from FFPE samples of patients with advanced or metastatic breast cancers treated with anti-aromatase and CDK4/6 inhibitors
|
Betz, M.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 35 |
76P Circadian control of neutrophil extracellular trap formation temporally regulates metastatic lung cancer progression
|
Milette, S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 36 |
114P Circulating microRNAs and response to oncological and surgical therapy in patients with locally advanced gastric cancer
|
Kokala-Dimitropoulou, V.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 37 |
15P ClinBioNGS: An integrated clinical bioinformatics pipeline for the analysis of somatic NGS cancer panels
|
Sole, X.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 38 |
106P Clinical application of next-generation sequencing in metastatic colorectal cancer (mCRC): Experience from a comprehensive cancer centre
|
Garulo, D. Lluís
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 39 |
57P Clinical characteristics and outcomes in non-small cell lung cancer (NSCLC) with tumour and germline BRCA1/2 mutations
|
Arthur, G.N.J.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 40 |
50P Clinical impact of actionable molecular variants disclosed in late-stage cancer patients by tumor whole-exome sequencing in a prospective single-institution study
|
Mapendano, C.K.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 41 |
121P Clinical outcomes of compound EGFR mutation in non-small cell lung cancer: A national, retrospective, multicenter study
|
Brindel, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 42 |
164P Clinical utility of comprehensive molecular profiling tests for advanced gastrointestinal tumors
|
Lebedeva, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 43 |
28P Collagen-activated signalling pathway is significantly hypermethylated in high-grade serous ovarian cancer (HGSOC) patients treated with platinum-containing neoadjuvant chemotherapy (NACT)
|
Fidalgo, J.A. Perez
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 44 |
125P Combination of navitoclax with alpelisib and trametinib to synergistically impair cell viability in high-grade ovarian cancer
|
Wozelka-Oltjan, L.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 45 |
36P Comparison of pelitinib, tepotinib or docetaxel efficacy according to the copy number or gene alteration status of EGFR, MET, HRAS, KRAS and NRAS genes
|
Zang, D.Y.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 46 |
99P Comprehensive genomic sequencing as an ancillary diagnostic tool for pathologists
|
Miller, D.R.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 47 |
144P Correlation of EZH2 expression and response to chemoradiotherapy in patients with locally advanced inoperable oral cavity and oropharyngeal squamous cell cancers
|
Ahmed, S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 48 |
133P Cytotoxic efficacy of artificial vesicles obtained from CAR-T cells by ultrasonication
|
Zmievskaya, E.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 49 |
78P Daily rhythmic expression of pro-tumoral programs in NSCLC shape cancer immunity and therapy response
|
de Juan, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 50 |
61P Deconvoluting the intra-tumour heterogeneity and subclonal evolution of CDK4/6 inhibitor resistance in ER+ breast cancer
|
Mavrommatis, I.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 51 |
119P De novo and histologically transformed small-cell lung cancer is sensitive to lurbinectedin treatment through the modulation of EMT and NOTCH signaling pathways
|
Sen, T.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 52 |
151P Development of a predictive model for response to neoadjuvant chemoradiation therapy of rectal cancer using the immunologic profile
|
Shin, E.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 53 |
111P Development of digital PCR for accurate measurement of HER2 amplification in 184 gastric cancer patients
|
Kang, S.Y.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 54 |
47P Differential expression of discriminative markers in matched invasion fronts and tumour buds in CRC
|
Grech, L.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 55 |
134P Doxorubicin and olaparib (OLA) synergism in high-grade serous ovarian (HGOC) and triple-negative breast cancer (TNBC) cell lines with olaparib-resistance
|
Fidalgo, J.A. Perez
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 56 |
73P Effect of combination therapy with atezolizumab plus metformin on peripheral immune cells from NSCLC patients
|
Amato, L.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 57 |
126P Effect of sequential antitumoral treatment with immune checkpoint blockade and tyrosine kinase inhibitors in hepatocellular carcinoma
|
Ciaramella, V.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 58 |
20P Effects of Apis dorsata honey on the expression of selected CYP450, pro-apoptotic, and anti-apoptotic genes during induced cytotoxicity in cyclophosphamide-treated human lung carcinoma (A549) cells
|
Narag, J.K.T.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 59 |
55P EGFR variant allele frequency (VAF) impacts on metastatic NSCLC patients outcome during first-line osimertinib
|
Riva, S.T.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 60 |
35P Enhancing efficacy of the MEK inhibitor trametinib in KRAS-mutated colorectal cancer cells
|
Ellis, L.M.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 61 |
158P Enhancing the communication of genomic results: Understanding patient and clinician perspectives
|
Johnston, E.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 62 |
88P Evaluating the infiltration of anti-NKG2DL CAR-T cells into a 3D cell culture developed in a Vitvo cartridge bioreactor
|
Valiullina, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 63 |
113P Evaluation of effects of tissue preservation methods on the proteome abundance through deep proteomics of breast cancer tissue
|
Parihari, S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 64 |
83P Evaluation of serum macrophage inhibitory cytokine 1 as a diagnostic biomarker for pancreatic cancer: A systematic review and diagnostic accuracy meta-analysis
|
Elfaituri, M.K.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 65 |
165P Evaluation of the mutational profile in patients with metastatic non-small cell lung carcinoma diagnosed in a tertiary hospital which was performed by NGS method
|
Deka, K.J.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 66 |
137P Event-free survival prediction using lncRNAs in pediatric B-cell acute lymphoblastic leukemia
|
Illarregi, U.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 67 |
138P Exome sequencing analysis for the identification of actionable mutations related to neoadjuvant chemotherapy response in locally advanced breast cancer
|
López, X.C.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 68 |
14P expHRD: An algorithm for the transcriptome-based estimation of homologous recombination deficiency score
|
Lee, J-K.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 69 |
22P Exploring exportin-1 as a therapeutic vulnerability in lung squamous cell carcinoma
|
Durani, V.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 70 |
44P Exploring miR-205 and miR-296 as salivary biomarkers and potential therapeutic targets in oral cancer
|
Milan, T. Moré
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 71 |
32P Expression of STAT3 and hypoxia markers in repeatedly resected glioma patients
|
Dvorakova, K.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 72 |
51P Functional characterization of the novel long intergenic non-coding RNA-RFC4, a transcript regulating chromosomal instability in prostate cancer
|
Manríquez, R. Montiel
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 73 |
34P Functional diagnostics and ex-vivo screening of erlotinib and nintedanib in non-small cell lung carcinoma: Implications for multidrug resistance and personalized therapy
|
Dinić, J.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 74 |
143P Genomic characterization and outcomes of patients with primary sclerosing cholangitis-related cholangiocarcinoma
|
Haro-Silerio, J.I.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 75 |
139P Genomic prognostic and potential theragnostic factors in anal squamous cell carcinoma treated with abdominoperineal resection
|
Hamza, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 76 |
94P Harnessing circulating tumor DNA in bronchoalveolar lavage fluid for precise molecular diagnosis of NSCLC
|
Borm, F.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 77 |
53P Heterogeneous characteristics of KRAS mutation subtypes in surgically resected lung adenocarcinomas
|
Takamochi, K.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 78 |
24P High-throughput plasma proteomics profiling in early breast cancer
|
Lombardo, I.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 79 |
41P HLA genotypes modify the age-related penetrance of BRCA1 pathogenic variants in breast cancer patients
|
Kuligina, E.S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 80 |
117P Homologous recombination deficiency (HRD) by shallow whole genome sequencing (sWGS): Seamless integration in an existing NGS somatic oncology workflow
|
Muller, E.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 81 |
21P Hsa_circ_0009061 inhibits the progression of bladder cancer through the miR-889-3p/CPEB3 axis
|
Wu, M.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 82 |
104P Hypomethylated immune gene promoters as potential biomarkers in oral and oropharyngeal cancer
|
Anić, P.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 83 |
23P Identification of HPSE as potential novel therapeutic target for lung adenocarcinoma patients
|
Doré, S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 84 |
145P Identification of next generation sequencing (NGS)-based genomic signature predicting resistance to immunotherapy (IO) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC): A single-center cohort study
|
Vitale, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 85 |
148P Identification of potential predictive biomarkers for ovarian cancer chemotherapy response
|
Nurgalieva, A.K.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 86 |
31P Identification of proteins associated with mRNA processing and maturation by quantitative proteomic analysis in Indian cervical cancer patients
|
Mukherjee, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 87 |
89P Immune homeostasis mediators and disease progression in chemotherapy-naïve and neoadjuvant chemotherapy treated gastric cancer patients
|
Kokala-Dimitropoulou, V.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 88 |
141P Immune-related epigenomic and transcriptomic signatures to predict immunotherapy response in NSCLC
|
Gallardo-Gómez, M.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 89 |
25P Immunohistochemical analysis of ROR1 and BMI-1 expression in luminal breast cancer
|
Vtorushin, S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 90 |
163P Impact of genomic sequencing data on treatment decisions in advanced breast cancer (ABC)
|
Chekhun, S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 91 |
105P Implementation of technical improvements in cfMeDIP-Seq library preparation
|
Dameri, M.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 92 |
123P Incidence and outcomes of anaplastic lymphoma kinase (ALK) and ROS 1 positive advanced NSCLC: A real world experience
|
Bala, S.C.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 93 |
70P Individualising methotrexate dose based on MTHFR gene polymorphisms in acute lymphoblastic leukemia
|
Konatam, M.L.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 94 |
67P Inflammation status and sarcopenia synergistically impact outcomes in cancer patients (pt) treated with ImmunOtherapy (IO) within the framework of a Molecular Pre-screening program (MP) and a spEcial Medication (ME) program
|
Rincon, L. Notario
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 95 |
69P Integrated OMIC analysis reveals arginine and proline metabolism plays critical role in hypoxia-induced oral squamous cell carcinoma
|
Singh, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 96 |
45P Integrative analysis of TCGA DNA methylation, RNA-sequencing, and variant dataset using machine learning in predicting endometrial cancer recurrence
|
Hong, J.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 97 |
42P Investigating the influence of extrachromosomal DNA in the progression of non-small cell lung cancer through the TRACERx and PEACE studies
|
Kittel, J.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 98 |
16P Investigation of c-MYC role in DNA-PK-mediated activation of STING pathway in SCLC
|
de Rosa, C.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 99 |
170P KRAS status in patients with pancreatic ductal adenocarcinoma: A single-center study from 2020 to 2023
|
Manukyan, M.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 100 |
98P Liquid biopsy in NSCLC: A promising tool to predict immunotherapy response
|
Fernández, A.O.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 101 |
87P Macrophage ontogeny underlies functional programs and drives brain tumor progression
|
Yu, M.W.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 102 |
43P MDM2 alterations in primary brain tumors: A potential niche for targeted therapy
|
Puerto, D.A. Gomez
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 103 |
66P Metabolic regulation of GMP- and MDP-derived macrophages in glioblastoma
|
Wilson, L.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 104 |
102P MicroRNAs in urine and saliva as non-invasive biomarkers of minimal residual disease in pediatric acute lymphoblastic leukemia
|
Pando-Caciano, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 105 |
49P MiR-155 promotes breast cancer progression by upregulating cancer stemness
|
Han, J.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 106 |
167P Molecular analysis of gastrointestinal stromal tumor (GIST): The experience of Regina Elena National Cancer Institute
|
Torchia, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 107 |
136P Molecular correlates of drug response to guide therapy in TNBC
|
Merrill, N.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 108 |
118P Molecular diagnostics of gastrointestinal stromal tumors in the era of precision oncology
|
Kalfusova, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 109 |
58P Molecular investigation using microarray-based comparative genomic hybridization in patients with myelodysplastic syndrome and normal karyotype
|
Ammar, M.A.N.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 110 |
156P Molecularly driven therapy recommended by a molecular tumor board: Accessible option or privilege for a minority of patients? A single-center experience from the Czech Republic
|
Eid, M.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 111 |
122P Molecular testing, treatment, and response of patients with advanced solid tumors harboring an NTRK gene fusion: Second interim results of the REALTRK registry
|
Lange, S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 112 |
103P MSI detection by NGS using tumor samples and liquid biopsy for patients with solid tumors: A single institution experience
|
Lebedeva, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 113 |
110P Multicellular three-dimensional tumor spheroid of nasopharyngeal carcinoma
|
Cheah, S.C.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 114 |
37P NET-mediated radio-resistance in early-stage non-small cell lung cancer
|
Ryan, M.I.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 115 |
128P Network medicine approach identifies small molecule drugs as immune checkpoint inhibitors repurposable for rectal cancer
|
Ahmed, F.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 116 |
90P Neutrophils as producers of endothelial growth factor in the progression of kidney cancer
|
Myagdieva, I.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 117 |
127P Novel bone-targeting of activatable sirolimus for targeted therapy of bone-resident cancers
|
Sadra, A.R.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 118 |
132P Novel small molecule modulators for activation of mutant tumor suppressor p53
|
Davletshin, D.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 119 |
17P NRF2 activation promotes HER2-targeted tolerance and resistance in oesophageal adenocarcinoma through metabolic reprogramming to glutathione
|
Zhang, W.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 120 |
77P Obesity-induced monocyte rewiring to enhance colorectal cancer liver metastasis
|
Varol, O.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 121 |
74P Obesity regulates tumor progression and sensitivity to checkpoint blockade through the diet-microbiota-immunity axis
|
Desharnais, L.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 122 |
173P Overcoming monocyte imbalance and T cell exhaustion in obesity-associated colorectal cancer liver metastasis
|
Cristea, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 123 |
101P Patient-derived organoids to optimize CDK4/6 inhibitor-based treatment selection in early breast cancer
|
Alves, C.L.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 124 |
157P PCM4EU academy: An educational program for precision oncology
|
Verlingue, L.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 125 |
161P PDL1 expression and its relation to EML4-ALK gene variants in metastatic lung adenocarcinoma: A single-center real-world experience
|
Meedimale, S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 126 |
75P Possible significance of the proline at position 325 in the recognition of the MX35 epitope of the NaPi2b transporter by monoclonal antibodies
|
Bulatova, L.F.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 127 |
159P Precision medicine-based platform to guide the treatment of EML4-ALK fusion lung cancers and other NSCLC
|
Merrill, N.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 128 |
140P Predictive value of DNA damage response and repair gene alterations and neoscore for neoadjuvant immunotherapies in non-small cell lung cancer
|
Feng, F.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 129 |
84P Profiling of lipid-loaded macrophages in melanoma
|
Pandini, M.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 130 |
97P Prospects of liquid biopsy in determining prognosis in children with HGG and DIPG
|
Regentova, O.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 131 |
27P Proteomic profiling reveals organ-specific differences in metastases and identifies potential biomarkers for recurrence risk in localized colon cancer
|
García-Micó, B.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 132 |
29P Quantitative tissue analysis reveal adenylate kinase 2 protein signatures: Therapeutic target for meningioma
|
Rana, R.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 133 |
149P Rare RAS mutations are associated with recurrence patterns and recurrence-free survival in colon cancer: First results from Morocco
|
Agy, F.E.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 134 |
11P Reconstructing tumour evolution of single cells using both somatic mutations and copy-number alterations
|
Zaidi, R.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 135 |
92P Reduction in the relative lymphocyte count as a predictive biomarker for serious immune-related adverse events in patients with metastatic non-small cell lung cancer on immunotherapy: Single institution experience
|
Garev, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 136 |
86P Regulation of cancer progression through the gut microbiome and immuno-nutrition
|
Swaby, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 137 |
129P Repurposing existing therapies for adrenal cancer: Unlocking new possibilities
|
Samantasinghar, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 138 |
130P Restoration of the mutant p53 protein upon treatment with small molecule modulators
|
Gilyazova, E.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 139 |
142P Role and impact of hypoxia-inducible factor 1-alpha on survival rates in pancreatic cancer: A systematic review and meta-analysis
|
Elfaituri, M.K.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 140 |
62P Role of IL6 (C-174G) polymorphism in the development of cervical intraepithelial neoplasia
|
Abakumova, T.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 141 |
30P Role of microRNA and CDKN2A/p16INK4a expression in the prognostication of oral squamous cell carcinoma
|
Burtyn, O.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 142 |
72P Role of pyruvate carboxykinase 2 upregulation in group 3 medulloblastoma: Implications for metabolic reprogramming and therapeutic strategies
|
Pai, M.G.J.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 143 |
81P Single-cell spatial landscape of NSCLC reveals subtype specific immune features
|
Sorin, M.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 144 |
71P Single nucleotide polymorphisms in the folate metabolic pathway genes and global DNA methylation in ovarian cancer
|
Surmava, S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 145 |
60P Spindle cell sarcomas with tyrosine kinase rearrangement
|
Krsková, L.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 146 |
100P Standard serum biomarkers to help predict a cancer diagnosis in patients with non-specific symptoms: Data from Guy´s rapid diagnostic clinic
|
Iglesias, M.J. Monroy
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 147 |
19P Stratified control study on neuroendocrine differentiation and potential clinical markers in patients with limited-stage small-cell lung cancer
|
Liu, L.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 148 |
172P Survival prediction using CT based radiomic features in patients of pancreatic cancer treated by chemotherapy followed by SBRT: A pilot study
|
Khosla, D.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 149 |
12P Swiss-PO: Molecular modelling for precision oncology
|
Krebs, F.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 150 |
116P Switching to a multigenic parallel sequencing approach: The landscape of biomarkers profiling changing between immunohistochemistry and next generation sequencing advantages and sustainability from a public hospital in Northern Italy
|
Ghirardi, G.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 151 |
166P Targeted next-generation sequencing as reliable detection of genetic profile for cancer treatment to guide oncologists in Pakistan
|
Ahmed, Z.A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 152 |
52P The concentration of mutated copies of driver genes in plasma closely mirrors the disease course in colorectal cancer, lung cancer, and melanoma patients
|
Kuligina, E.S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 153 |
63P The impact of disruption of melatonin secretion on the structural-functional changes of the microbiome and the role of the melatonin-microbiome axis in the initiation of carcinogenesis
|
Tavartkiladze, A.A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 154 |
154P The impact of proton pump inhibitors in the prognosis of patients with non-metastatic nasopharyngeal carcinoma
|
Martins, J.A. Barbosa
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 155 |
91P The impact of the immunological context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: A systematic review
|
Mubarak, O.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 156 |
146P The prognosis value of heat-shock proteins in esophagogastric cancer: A systematic review and meta-analysis
|
Nakamura, E.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 157 |
46P The role of microRNA-1246 in early detection of breast cancer: Findings from a systematic review and meta-analysis
|
Elfaituri, M.K.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 158 |
68P The role of systemic reprogramming of GMPs in improving outcomes in glioblastoma
|
Atallah, A.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 159 |
39P The use of antibiotics or proton pump inhibitors and the response to intravesical Bacillus Calmette Guérin therapy in non-muscle-invasive bladder cancer
|
Martins, J.A. Barbosa
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 160 |
48P Transcriptome profiling highlights distinct gene signatures in HER2 high (HER2 3+) and HER 2 low (Her2 1+/2+) breast cancers
|
Thakur, T.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 161 |
65P Transmembrane distribution of phosphatidylethanolamine in plasma membrane of ovarian cancer cells under conditions mimicking tumor microenvironment
|
Savenkova, D.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 162 |
131P Trop 2 and its overexpression in metastatic colorectal cancer patients (mCRCp): Biological, clinical and therapeutic implications
|
Petricca, A. Mancuso
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 163 |
82P Tumor cell-released autophagosomes (TRAPs) promote breast cancer lung metastasis by modulating neutrophil extracellular traps formation
|
Zhou, X.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 164 |
79P Tumor cell-released autophagosomes (TRAPs) remodel the breast tumor microenvironment by inducing the formation of inflammatory cancer-associated fibroblasts (CAFs)
|
Wu, C.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 165 |
80P Tumor microenvironment (TME) defines prognosis of EGFR-mutant non-small cell lung cancer (NSCLC)
|
Zullo, L.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 166 |
59P Unraveling methylation signatures in RAS/BRAF wild-type colorectal cancer patients to identify predictive biomarkers for anti-epidermal growth factor receptor therapy
|
de Abreu, A.R.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 167 |
33P Unraveling the mechanisms of cisplatin resistance in bladder organoid by single cell RNA sequencing
|
Xie, T.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 168 |
107P Unveiling mismatch repair deficiency (dMMR) and microsatellite-instability high (MSI-H) detection in cancer patients (pt) using a next-generation sequencing (NGS)-based molecular pre-screening program (MPP)
|
Rincon, L. Notario
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 169 |
168P Usefulness of liquid biopsy in the management of patients with advanced or metastatic pancreatic cancer
|
Barreira, J.J. Iranzo
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 170 |
155P Use of machine learning for the identification of molecular biomarkers to predict response to neoadjuvant chemotherapy in locally advanced breast cancer patients
|
Del Río Pisula, M.S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 171 |
108P Validation and implementation of a large NGS panel to test liquid biopsies from patients with suspected advanced non-small cell lung cancer (NSCLC) in an NHS genomic laboratory for the QuicDNA biomarker study
|
Dodds, R.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 172 |
85P Whole-genome CRISPR screening identifies chemosensor receptors as key regulators of the cancer-macrophage crosstalk
|
Marelli, G.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 173 |
40P YAP1 promotes sorafenib resistance by activation of TGFβ signaling pathway
|
Chee, C.L.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 174 |
Table of Contents
|
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 175 |
174TiP A pivotal clinical trial of a functional ex vivo organ culture assay for cancer precision medicine
|
Hanks, S.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 176 |
177TiP Myeloid-derived suppressor cells in the peripheral blood of patients with colorectal cancer: A trial in progress
|
Raskov, H.
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 177 |
Title Page
|
|
|
|
8 |
1S5 |
p.
|
artikel
|
| 178 |
UNICANCER
|
|
|
|
8 |
1S5 |
p.
|
artikel
|
Tijdschrift beschrijving